NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

勃起功能障礙藥市場調查報告:藥物,各投藥法,各終端用戶-2025年前的預測-COVID-19累積的影響

Erectile Dysfunction Drugs Market Research Report by Drug (Avanafil, Muse Suppository, and Sildenafil ), by Mode of Administration, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 995401
出版日期 內容資訊 英文 194 Pages
商品交期: 最快1-2個工作天內
價格
勃起功能障礙藥市場調查報告:藥物,各投藥法,各終端用戶-2025年前的預測-COVID-19累積的影響 Erectile Dysfunction Drugs Market Research Report by Drug (Avanafil, Muse Suppository, and Sildenafil ), by Mode of Administration, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 194 Pages
簡介

全球勃起功能障礙藥的市場規模預測將從2020年的19億6,840萬美元,擴大到2025年末的26億8,261萬美元。

COVID-19是前所未有的全球性公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們窮究潛在的COVID-19問題和未來路徑。該報告考慮了消費者行為和需求的變化,購買方式,供應鏈的重新改道,當前市場趨勢以及政府的重要介入等因素,提供有關COVID-19的洞察。

本報告提供勃起功能障礙藥市場相關調查,提供市場概要,以及藥物,各投藥法,各終端用戶,各地區的趨勢,COVID-19累積的影響,及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和範圍
  • 調查對象年
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 計劃:調查計劃作成
    • 實行:調查實施
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 簡介
  • 市場預測
  • 各藥物預測
  • 各投藥法預測
  • 各終端用戶預測
  • 各地區預測
  • 其他競爭公司預測

第4章 市場概要

  • 簡介
  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特五力分析
    • 新加入廠商業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章 全球勃起功能障礙藥市場,各藥物

  • Avanafil
  • 繆斯栓劑(Alprostadil)
  • Sildenafil
  • Tadalafil
  • Vardenafil

第7章 全球勃起功能障礙藥市場,各投藥法

  • 注射
  • 口服
  • 局部

第8章 全球勃起功能障礙藥市場,各終端用戶

  • 醫院藥局
  • 線上藥局
  • 零售藥局

第9章 南北美洲的勃起功能障礙藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區的勃起功能障礙藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第11章 歐洲,中東·非洲的勃起功能障礙藥市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第12章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及夥伴關係
    • 銷售與強化新產品
    • 投資與資金籌措
    • 獎,獎勵,擴大

第13章 企業的實用性簡介

  • Apricus Biosciences Inc.
  • Aurobindo Pharma Ltd
  • Bayer AG
  • Cipla Ltd
  • Cristalia Produtos Quimicos Farmaceuticos Ltd.
  • Dong-A Pharmaceutical Co. Ltd.
  • Dr. Reddys Laboratories Ltd
  • Eli Lilly and Company
  • Endo International PLC
  • Ferring Pharmaceuticals
  • Futura Medical PLC
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc
  • Meda Pharmaceuticals, Inc.
  • Metuchen Pharmaceuticals LLC
  • Mylan N.V.
  • Novartis International AG
  • Pfizer, Inc.
  • Promedon HQ
  • S.K. Chemicals Co. Ltd.
  • Teva Pharmaceutical Industries Ltd
  • Torrent Pharmaceuticals Ltd
  • Vivus, Inc.

第14章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-4348D129FAF5

The Global Erectile Dysfunction Drugs Market size was estimated at USD 1,968.40 Million in 2020 and expected to reach USD 2,103.97 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.22% to reach USD 2,991.58 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Erectile Dysfunction Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Drug, the Erectile Dysfunction Drugs Market was studied across Avanafil (Stendra), Muse Suppository (Alprostadil), Sildenafil (Viagra), Tadalafil (Cialis), and Vardenafil (Levitra, Staxyn).

Based on Mode of Administration, the Erectile Dysfunction Drugs Market was studied across Injections, Oral, and Topical.

Based on End-User, the Erectile Dysfunction Drugs Market was studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.

Based on Geography, the Erectile Dysfunction Drugs Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Erectile Dysfunction Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Erectile Dysfunction Drugs Market, including Apricus Biosciences Inc., Aurobindo Pharma Ltd, Bayer AG, Cipla Ltd, Cristalia Produtos Quimicos Farmaceuticos Ltd., Dong-A Pharmaceutical Co. Ltd., Dr. Reddys Laboratories Ltd, Eli Lilly and Company, Endo International PLC, Ferring Pharmaceuticals, Futura Medical PLC, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc, Meda Pharmaceuticals, Inc., Metuchen Pharmaceuticals LLC, Mylan N.V., Novartis International AG, Pfizer, Inc., Promedon HQ, S.K. Chemicals Co. Ltd., Teva Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Ltd, and Vivus, Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Erectile Dysfunction Drugs Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Erectile Dysfunction Drugs Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Erectile Dysfunction Drugs Market?
  • 4. What is the competitive strategic window for opportunities in the Global Erectile Dysfunction Drugs Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Erectile Dysfunction Drugs Market?
  • 6. What is the market share of the leading vendors in the Global Erectile Dysfunction Drugs Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Erectile Dysfunction Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Drug Outlook
  • 3.4. Mode of Administration Outlook
  • 3.5. End-User Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in patient awareness and education levels
      • 5.1.1.2. Growing portion of geriatric population
      • 5.1.1.3. Rising adoption of a sedentary lifestyle and incidence of lifestyle diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects associated with the erectile dysfunction drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Government reforms and public awareness initiatives in developing nations
      • 5.1.3.2. R&D focused on developments of effective therapies and treatments for erectile dysfunction
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of cost-effective counterfeit drugs
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Erectile Dysfunction Drugs Market, by Drug

  • 6.1. Introduction
  • 6.2. Avanafil (Stendra)
  • 6.3. Muse Suppository (Alprostadil)
  • 6.4. Sildenafil (Viagra)
  • 6.5. Tadalafil (Cialis)
  • 6.6. Vardenafil (Levitra, Staxyn)

7. Erectile Dysfunction Drugs Market, by Mode of Administration

  • 7.1. Introduction
  • 7.2. Injections
  • 7.3. Oral
  • 7.4. Topical

8. Erectile Dysfunction Drugs Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Americas Erectile Dysfunction Drugs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Erectile Dysfunction Drugs Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Erectile Dysfunction Drugs Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Apricus Biosciences Inc.
  • 13.2. Aurobindo Pharma Ltd
  • 13.3. Bayer AG
  • 13.4. Cipla Ltd
  • 13.5. Cristalia Produtos Quimicos Farmaceuticos Ltd.
  • 13.6. Dong-A Pharmaceutical Co. Ltd.
  • 13.7. Dr. Reddys Laboratories Ltd
  • 13.8. Eli Lilly and Company
  • 13.9. Endo International PLC
  • 13.10. Ferring Pharmaceuticals
  • 13.11. Futura Medical PLC
  • 13.12. GlaxoSmithKline PLC
  • 13.13. Johnson & Johnson Services, Inc
  • 13.14. Meda Pharmaceuticals, Inc.
  • 13.15. Metuchen Pharmaceuticals LLC
  • 13.16. Mylan N.V.
  • 13.17. Novartis International AG
  • 13.18. Pfizer, Inc.
  • 13.19. Promedon HQ
  • 13.20. S.K. Chemicals Co. Ltd.
  • 13.21. Teva Pharmaceutical Industries Ltd
  • 13.22. Torrent Pharmaceuticals Ltd
  • 13.23. Vivus, Inc.

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2026
  • FIGURE 11. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY AVANAFIL (STENDRA), 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY AVANAFIL (STENDRA), BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MUSE SUPPOSITORY (ALPROSTADIL), 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MUSE SUPPOSITORY (ALPROSTADIL), BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY SILDENAFIL (VIAGRA), 2018-2026 (USD MILLION)
  • FIGURE 16. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY SILDENAFIL (VIAGRA), BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY TADALAFIL (CIALIS), 2018-2026 (USD MILLION)
  • FIGURE 18. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY TADALAFIL (CIALIS), BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY VARDENAFIL (LEVITRA, STAXYN), 2018-2026 (USD MILLION)
  • FIGURE 20. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY VARDENAFIL (LEVITRA, STAXYN), BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2020 VS 2026 (%)
  • FIGURE 22. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2026
  • FIGURE 24. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY INJECTIONS, 2018-2026 (USD MILLION)
  • FIGURE 25. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY INJECTIONS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY ORAL, 2018-2026 (USD MILLION)
  • FIGURE 27. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 28. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY TOPICAL, 2018-2026 (USD MILLION)
  • FIGURE 29. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY TOPICAL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 30. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
  • FIGURE 31. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2026
  • FIGURE 33. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2026 (USD MILLION)
  • FIGURE 34. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 35. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2026 (USD MILLION)
  • FIGURE 36. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 37. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2026 (USD MILLION)
  • FIGURE 38. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 39. AMERICAS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 40. AMERICAS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 42. ARGENTINA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. BRAZIL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. CANADA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. MEXICO ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. UNITED STATES ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. CALIFORNIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. FLORIDA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. ILLINOIS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. NEW YORK ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. OHIO ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. PENNSYLVANIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. TEXAS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. ASIA-PACIFIC ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 55. ASIA-PACIFIC ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 56. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 57. CHINA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. INDIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. INDONESIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. JAPAN ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. MALAYSIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. PHILIPPINES ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. SOUTH KOREA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. THAILAND ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. EUROPE, MIDDLE EAST & AFRICA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 66. EUROPE, MIDDLE EAST & AFRICA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 67. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 68. FRANCE ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. GERMANY ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 70. ITALY ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. NETHERLANDS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 72. QATAR ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. RUSSIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 74. SAUDI ARABIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 75. SOUTH AFRICA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 76. SPAIN ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 77. UNITED ARAB EMIRATES ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 78. UNITED KINGDOM ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 79. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 80. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 81. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 82. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY AVANAFIL (STENDRA), BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MUSE SUPPOSITORY (ALPROSTADIL), BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY SILDENAFIL (VIAGRA), BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY TADALAFIL (CIALIS), BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY VARDENAFIL (LEVITRA, STAXYN), BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY INJECTIONS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY TOPICAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. AMERICAS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. AMERICAS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. AMERICAS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. AMERICAS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. ARGENTINA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. ARGENTINA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. ARGENTINA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. BRAZIL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. BRAZIL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. BRAZIL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. CANADA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. CANADA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. CANADA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. MEXICO ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. MEXICO ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. MEXICO ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. UNITED STATES ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. UNITED STATES ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. UNITED STATES ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. UNITED STATES ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. CALIFORNIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. CALIFORNIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. CALIFORNIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. FLORIDA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. FLORIDA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. FLORIDA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. ILLINOIS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. ILLINOIS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. ILLINOIS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. NEW YORK ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. NEW YORK ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. NEW YORK ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. OHIO ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. OHIO ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. OHIO ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. PENNSYLVANIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. PENNSYLVANIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. PENNSYLVANIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. TEXAS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. TEXAS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. TEXAS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. ASIA-PACIFIC ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. ASIA-PACIFIC ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. ASIA-PACIFIC ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. ASIA-PACIFIC ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. CHINA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. CHINA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. CHINA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. INDIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. INDIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. INDIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. INDONESIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. INDONESIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. INDONESIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. JAPAN ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. JAPAN ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. JAPAN ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. MALAYSIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. MALAYSIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. MALAYSIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. PHILIPPINES ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. PHILIPPINES ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. PHILIPPINES ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. SOUTH KOREA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. SOUTH KOREA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. SOUTH KOREA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. THAILAND ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. THAILAND ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. THAILAND ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. FRANCE ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. FRANCE ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. FRANCE ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. GERMANY ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. GERMANY ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. GERMANY ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. ITALY ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. ITALY ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. ITALY ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. NETHERLANDS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. NETHERLANDS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. NETHERLANDS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. QATAR ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. QATAR ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. QATAR ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. RUSSIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. RUSSIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. RUSSIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. SAUDI ARABIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. SAUDI ARABIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. SAUDI ARABIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. SOUTH AFRICA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. SOUTH AFRICA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. SOUTH AFRICA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. SPAIN ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. SPAIN ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. SPAIN ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. UNITED ARAB EMIRATES ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. UNITED ARAB EMIRATES ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. UNITED ARAB EMIRATES ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. UNITED KINGDOM ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. UNITED KINGDOM ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. UNITED KINGDOM ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 123. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: SCORES
  • TABLE 124. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: BUSINESS STRATEGY
  • TABLE 125. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: PRODUCT SATISFACTION
  • TABLE 126. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: RANKING
  • TABLE 127. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 128. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 129. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: MERGER & ACQUISITION
  • TABLE 130. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 131. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 132. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: INVESTMENT & FUNDING
  • TABLE 133. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 134. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: LICENSE & PRICING
  • TABLE 135. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: CONTACT DETAILS